Ardelyx Inc.
Laura A Williams (Chief Patient Officer) sells ARDX shares
About this filing
Ardelyx Inc. (ARDX) filed Form 4 (insider transaction) with the SEC on Aug 25, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Laura A Williams · Chief Patient Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | S · open-market saleFootnotes F1 | −3,486 | $3.86 | $13,445.15 | 374,709 | Direct |
| Aug 21, 2026 | S · open-market saleFootnotes F1 | −3,089 | $3.86 | $11,913.96 | 371,620 | Direct |
| Aug 21, 2026 | S · open-market saleFootnotes F1 | −2,430 | $3.86 | $9,372.27 | 369,190 | Direct |
| Aug 21, 2026 | S · open-market saleFootnotes F1 | −1,734 | $3.86 | $6,687.86 | 367,456 | Direct |
Footnotes
- F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
More ARDX filings
- 4
Filed Aug 25, 2026
- 4
Filed Aug 25, 2026
- 4
Filed Aug 25, 2026
- 4
Filed Aug 25, 2026
- 4
Filed Aug 25, 2026
- 4
Filed Aug 25, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.